NCT05940298View on ClinicalTrials.gov

Molecular Imaging of Gastrin Releasing Peptide Receptors Using Labeled Technetium-99m DB8

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

July 3, 2023

Primary Completion Date

June 1, 2024

Study Completion Date

December 31, 2024

Conditions
Prostate CancerBreast Cancer
Interventions
DRUG

Intravenous injection of [99mTc]Tc-DB8

One single intravenous injection of \[99mTc\]Tc-DB8, followed by gamma camera imaging after 2, 4, 6 and 24 hours.

Trial Locations (1)

Unknown

TomskNRMC, Tomsk

All Listed Sponsors
collaborator

Uppsala University

OTHER

lead

Tomsk National Research Medical Center of the Russian Academy of Sciences

OTHER